Local News Geneticists Come Together to Ask: Why Do Some People Have Worse COVID-19 Symptoms Than Others? Broad Institute | April 14, 2020 Even early on in the COVID-19 pandemic, it quickly became clear that some people, like…sciencecityApril 14, 2020 Read More
Local News Evolution Can Quickly Change Cells’ Deepest Foundations Harvard University | April 13, 2020 Fumasoni and Murray show how evolution can quickly and reproducibly change conserved features involved in…sciencecityApril 13, 2020 Read More
Local News Making Headway on COVID-19 Research BU School of Medicine | April 13, 2020 First things first: in order to take out an enemy, you’ve got to be able…sciencecityApril 13, 2020 Read More
Local News The Wyss Institute’s Response to COVID-19: Beating Back the Coronavirus The Wyss Institute | April 10, 2020 The burgeoning coronavirus (COVID-19) global pandemic has already killed thousands of people worldwide and is…sciencecityApril 10, 2020 Read More
Local News Scientists Map Human Protein Interactions The Harvard Gazette | April 10, 2020 The human body is composed of billions of cells, each of which is made and…sciencecityApril 10, 2020 Read More
Local News Dana-Farber Scientists Bring Experience From SARS and MERS Outbreaks to Aid COVID-19 Research Dana-Farber Cancer Institute | April 9, 2020 As scientists race to develop and test new treatments for COVID-19, Dana-Farber’s Wayne Marasco, MD, PhD,…sciencecityApril 9, 2020 Read More
Local News BIDMC Launches Clinical Trial to Assess Common Anti-Clotting Medication for Treatment of COVID-19-Related Respiratory Failure Beth Israel Deaconess Medical Center | April 9, 2020 While the majority of people with COVID-19 won’t require hospitalization, those who do are likely…sciencecityApril 9, 2020 Read More
Local News Biotech Vet Gilman’s Startup Earns $190M-Plus in Roche Deal Boston Business Journal | April 9, 2020 "Honest to God, there are dozens of targets we could hit. We can afford to…sciencecityApril 9, 2020 Read More
Local News Former Gene-Silencing Rivals Bury the Hatchet with New Partnership Boston Business Journal | April 8, 2020 Former foes Alnylam Pharmaceuticals and Dicerna Pharmaceuticals Inc. are joining forces, with plans to work…sciencecityApril 8, 2020 Read More
Local News Boston Biomedical, Inc. Announces First Patient Dosed in Phase 1 Study of Investigational Agent TP-3654 in Patients with Myelofibrosis PR Newswire | April 8, 2020 Boston Biomedical, Inc. today announced the first patient has been dosed in a phase 1…sciencecityApril 8, 2020 Read More